Avsnitt

  • Episode Summary:
    Join us for an insightful conversation with Jordan Haworth, a leading GI physiologist, as we explore the fascinating world of gut health and its profound impact on overall wellness. Jordan’s unconventional journey into GI physiology began with a pivot from immunology, leading him to discover the essential role of the gut microbiome. From its connection to immune responses and mental health to its influence on conditions like IBS and SIBO, Jordan reveals the science and significance behind gut health.

    In this episode, Jordan shares how his personal and professional experiences have shaped his mission to combat misinformation about gut health. He emphasizes the importance of scientifically validated testing, such as hydrogen and methane breath tests, as key tools for diagnosing GI disorders and empowering patients with actionable insights.

    We’ll also delve into the dangers of fad diets and restrictive eating patterns, Jordan’s fight against pseudoscience, and his efforts to educate the public about the true meaning of a healthy gut.

    What You’ll Learn in This Episode:
    - How the gut microbiome influences digestion, immune health, and more.
    - The importance of scientifically validated testing for GI disorders.
    - The risks of misinformation and extreme dietary trends.
    - What defines true “gut health” and why balance is essential.
    - Jordan’s journey from immunology to GI physiology and his advocacy for evidence-based care.

    Memorable Quotes from Jordan:
    🗨️ "Gut health isn’t just about digestion—it impacts everything from immune responses to mental health. A balanced and diverse microbiome is essential for overall well-being."
    🗨️ "The long-term effects of restrictive diets are concerning. Eliminating foods might offer short-term relief, but reintroducing them is crucial for maintaining a healthy gut microbiome."

    Follow Jordan Haworth:
    🌐 [Functional Gut Clinic](https://thefunctionalgutclinic.com/about/team/jordan-haworth/)
    📷 [Instagram](https://www.instagram.com/mrguthealth/)
    💼 [LinkedIn](https://www.linkedin.com/in/jordan-haworth-467990142/?originalSubdomain=uk)

    Tune in for a deep dive into the science of gut health and practical tips for maintaining a healthy, balanced microbiome! Don’t miss this empowering episode.

  • In a recent conversation on Episode 5 of the Modern Gastro Podcast, Craig Strasnick, CEO of CDI, and Dr. Anthony Hobson, founder of the Functional Gut Clinic, explored their ongoing partnership and its impact. With nearly a decade of collaboration, their joint efforts have been instrumental in expanding access to advanced diagnostic tools for GI disorders, significantly influencing the field.

    The Partnership’s Evolution

    The collaboration between CDI and Functional Gut Diagnostics began in 2016 with a shared mission to address the complexities of functional GI disorders. Dr. Hobson, a multifaceted professional—clinician, business owner, physiologist, and academic researcher—detailed how his diverse roles converge to enhance the technologies they offer. The partnership’s goal is to integrate cutting-edge research with practical clinical applications to validate and improve diagnostic methods.

    Craig highlighted the critical role of academic research in shaping clinical practice. By leveraging public domain research and literature, they aim to demonstrate the clinical utility of their diagnostics, ensuring that new technologies are both effective and evidence-based. This integration of research and practice has been pivotal in advancing their diagnostic solutions.

    Hydrogen and Methane Breath Testing: A Cornerstone

    One of the standout aspects of their approach is the use of hydrogen and methane breath testing for diagnosing Small Intestinal Bacterial Overgrowth (SIBO) and other functional gut disorders. Dr. Hobson explained that breath testing has become a cornerstone of their methodology, providing valuable insights into conditions like SIBO and motility issues.

    Their research into breath testing has helped establish standard protocols and has influenced national guidelines in the UK. Despite some skepticism and resistance from parts of the medical community, the data supporting breath testing’s efficacy continues to grow. Dr. Hobson shared how this testing not only assists in diagnosis but also plays a crucial role in assessing treatment efficacy and guiding dietary modifications.

    The collaboration between CDI and the Functional Gut Clinic represents a significant advancement in the field of gastrointestinal diagnostics. By integrating academic research with clinical practice, maintaining a patient-centered focus, and addressing skepticism with evidence-based solutions, they are transforming the landscape of GI diagnostics.

    Follow Dr. Hobson:

    https://www.linkedin.com/in/anthony-hobson-028309a/ https://twitter.com/functionalgut https://www.facebook.com/FunctionalGutClinic
  • Saknas det avsnitt?

    Klicka här för att uppdatera flödet manuellt.

  • In this episode, we explore the creation and impact of Guide to the Guidelines: A Vignette-Based Journey Through the ACG Clinical Practice Guidelines, co-authored by Dr. Brennan Spiegel, MD, MSHS, FACG, and Dr. Hetal A. Karsan, MD, FACG, AGAF, FASGE, FAASLD, FACP. This innovative book offers a practical and engaging resource for GI clinicians, bridging the gap between academic guidelines and everyday clinical practice.

    The conversation begins with the story of their collaboration, dating back to their fellowship days at UCLA. They also share their individual journeys into gastroenterology, discussing how their passion for procedures, patient interaction, and the brain-gut axis led them to this field. The discussion then shifts to the creation of their book, which emerged from their previous work on GI board exam manuals and courses. The pandemic inspired them to create a resource that makes the vast amount of guideline information more accessible and memorable for clinicians. Through clinical vignettes, the book brings the ACG guidelines to life, offering a valuable tool for practicing GI clinicians. Guest Bios: Dr. Brennan Spiegel, MD, MSHS, FACG, is the Director of Health Services Research for Cedars-Sinai, the Director of the Cedars-Sinai Master's Degree Program in Health Delivery Science, the George and Dorothy Gourrich Chair in Digital Health Ethics, and the Director of the Cedars-Sinai Center for Outcomes Research and Education (CS-CORE). Dr. Hetal A. Karsan, MD, FACG, AGAF, FASGE, FAASLD, FACP, is a board certified gastroenterologist with United Digestive/Atlanta Gastroenterology and also serves as the Chair of United Digestive Medical Education and Adjunct Professor of Medicine at Emory University.
  • Welcome to the Modern Gastro podcast. Today's episode promises an enlightening discussion with Tamara Duker Freuman, a distinguished registered dietitian and author renowned for her expertise in digestive nutrition.

    Tamara, based in New York, is affectionately known as America's trusted digestive nutrition expert. With extensive experience at New York Gastroenterology Associates and author of two impactful books, including her latest release, "Regular," Tamara brings a wealth of knowledge to the table. She specializes in the dietary management of various gastrointestinal symptoms, digestive disorders, and food intolerances through her Manhattan-based practice.

    In addition to her clinical work, Tamara is a high-profile nutrition writer whose advice on healthy living and dietary management of digestive disease is read by hundreds of thousands of people each month via leading online media platforms. She also serves on the Medical Advisory Board of U.S. News. Her debut book, "The Bloated Belly Whisperer," is the first evidence-based guide to understanding and treating the many different causes of belly bloating and has been described as a "game-changer" for people suffering from chronic digestive upset. Her second book, "Regular," is a similarly evidence-based guide to understanding and treating the many different causes of chronic diarrhea and constipation.

    Tamara earned a Master of Science degree in Clinical Nutrition from New York University and completed her training at Mount Sinai Medical Center. She has been featured on ABC TV's Live with Kelly and Ryan and Good Morning America, and her advice has been featured in leading print, radio, and online outlets.

    In today's episode, we explore "Regular," inspired by Tamara's patients' inquiries about specific gastrointestinal conditions not fully addressed in her previous book. "Regular" aims to provide personalized solutions for irregular bowel patterns, emphasizing individuality and personalization in treatment plans.

    We delve into the importance of identifying the underlying cause of digestive issues and tailoring treatment plans accordingly. Common conditions such as irritable bowel syndrome (IBS), lactose intolerance, and pelvic floor dysfunction are highlighted. Tamara shares advice on seeking professional help for chronic gastrointestinal symptoms, emphasizing the significance of alarm symptoms and collaboration between healthcare providers and patients.

    Tamara elaborates on utilizing therapeutic diets as diagnostic tools to assess symptom response and guide further evaluation. Strategies for patient compliance with complex diets like the low FODMAP diet are discussed. She also acknowledges the profound impact of digestive health on overall quality of life and mental well-being, emphasizing the importance of symptom control for improved life satisfaction.

    The discussion concludes with insights into empowering healthcare providers with updated clinical practices and evidence-based solutions for digestive health, ensuring comprehensive support for patients. We express gratitude to Tamara for her invaluable insights and dedication to advancing gastrointestinal care. The mission to improve patient outcomes continues, fueled by ongoing dialogue and collaboration within the GI community.

    Thank you for joining us on this enlightening journey through the intricacies of digestive health. Stay connected with CDI on social media for more educational content and updates on the Modern Gastro Podcast. Until next time, let's continue exploring and making a positive impact on patients' lives. Thank you, Tamara, for an insightful conversation!

  • Unveiling Insights into Gastrointestinal Health

    In today's episode, we have the privilege of delving into a condition that impacts millions worldwide: irritable bowel syndrome (IBS). Joining us is Dr. Nitin Ahuja, a distinguished gastroenterologist and assistant professor at Penn Medicine. Together, we'll unravel the complexities of IBS diagnostics, treatment strategies, and its intriguing relationship with small intestinal bacterial overgrowth (SIBO).

    Nitin K. Ahuja, MD, MS, is Assistant Professor of Clinical Medicine and Co-Director, Program in Neurogastroenterology and Motility and in the Division of Gastroenterology and Hepatology at the University of Pennsylvania. He is also a board-certified gastroenterologist for Penn Medicine. His clinical interests are in motility disorders of the gastrointestinal tract, and his research interests are in the history, literature, and culture of medicine. He went to medical school at the University of Michigan, completed his residency at the University of Virginia, and completed his fellowship at the Johns Hopkins Hospital.

    Exploring the Landscape of IBS Diagnostics

    Dr. Ahuja kicks off our discussion by shedding light on the evolving landscape of IBS diagnostics. Traditionally, the focus has been on excluding other potential causes through tests like endoscopies and blood work. However, there's a shift towards identifying specific biomarkers of IBS, offering a more precise approach to therapy. Exciting advancements include exploring gut microenvironments and microbial signatures, as well as integrating psychological surveys to understand the holistic patient experience.

    Navigating the Intersection of Digestive and Mental Health

    Our conversation extends beyond physiological symptoms to the vital connection between digestive and mental health. Dr. Ahuja emphasizes the transition from viewing gastrointestinal issues as functional disorders to recognizing them as brain-gut interactions. By acknowledging this connection, clinicians can tailor treatments to address both physical and psychological aspects, ultimately enhancing patient care.

    Challenges in Patient Management and Therapeutic Strategies

    As we delve deeper, we confront the challenges of differentiating between similar conditions like IBS, SIBO, and GERD. Dr. Ahuja shares the complexities of interpreting diagnostic data, especially when patients arrive with preconceived notions based on external sources. Despite these challenges, he emphasizes the importance of honest patient-provider partnerships and the ongoing pursuit of diverse therapeutic options.

    Looking Ahead: Trends and Future Directions

    In our closing remarks, we contemplate the future of gastroenterology, envisioning a shift towards precision-based approaches and the integration of big data analytics. Dr. Ahuja underscores the importance of refining diagnostic terminology and leveraging emerging technologies to tailor therapies to individual patient phenotypes.

    As we wrap up this enriching conversation, I extend my heartfelt gratitude to Dr. Nitin Ahuja for sharing his expertise and insights. To our audience, thank you for joining us on this journey through the ever-evolving realm of functional GI disorders. Remember, the quest for knowledge and collaboration doesn't end here—keep the conversation alive on social media using the #GICommunity hashtag, and together, let's drive progress in digestive health.

  • Title: Unveiling the Modern Gastro Podcast: Episode 1

    Welcome to the premiere episode of the Modern Gastro podcast, where we delve deep into the world of gastroenterology, exploring the realms of functional gastroenterology with industry leaders. I'm Craig Strasnick, CEO of Commonwealth Diagnostics International (CDI), and your host for this exciting journey.

    From the outset, our aim with this podcast is clear: to transcend the surface and venture into the heart of gastroenterology, unraveling the complexities that merge personal, scientific, and business dimensions within this captivating field.

    Reflecting on my journey, I share a profound realization sparked by my father's influence. Witnessing his dedication as a practicing clinician, I recognized the desire to make a meaningful impact beyond mere business endeavors. This fusion of ambition and purpose crystallized during my formative years, laying the foundation for my career trajectory.

    The landscape of gastroenterology has evolved, presenting novel challenges and opportunities. Amidst this transformation, CDI strives to deepen its impact by fostering collaborations with emerging talents and seasoned practitioners alike. By bridging the gap between entrenched mindsets and innovative approaches, we aim to enhance patient care and outcomes.

    In this inaugural episode, we navigate the intricate interplay between gut and brain, emphasizing the significance of functional gastrointestinal disorders. Through advancements in diagnostic tools and therapeutic interventions, we endeavor to illuminate pathways to improve patient well-being.

    Our podcast serves as a platform for diverse voices to converge, offering insights from clinicians, business leaders, and industry pioneers. By fostering dialogue and exchange, we aim to catalyze innovation and drive progress in gastroenterology.

    As we embark on this journey together, I invite you to join us in exploring the dynamic landscape of modern gastroenterology. Together, let's unravel the complexities, forge new connections, and pave the way for a brighter future in patient care.

    Thank you for tuning in to the Modern Gastro podcast. Stay connected with us on our website and social media channels for updates and exclusive content. Until next time, here's to a journey filled with discovery, collaboration, and meaningful impact.